Kathiresan is a cardiologist and a geneticist who has helped define the inherited basis for heart attack risk and made groundbreaking discoveries of genetic mutations which confer resistance to cardiovascular disease.
[1] Prior to joining Verve in July 2019, he served as director of the Massachusetts General Hospital Center for Genomic Medicine and was the Ofer and Shelly Nemirovsky MGH Research Scholar.
He also served as director of the Cardiovascular Disease Initiative at the Broad Institute and was a Professor of Medicine at Harvard Medical School.
Kathiresan’s research laboratory focused on understanding the inherited basis for blood lipids and myocardial infarction and using these insights to improve preventive cardiac care.
Kathiresan pursued postdoctoral research training from 2003 to 2008 in cardiovascular genetics through a combined experience at the Broad Institute and the Framingham Heart Study, jointly mentored by Drs.